Drug intelligence / Profile preview

Luole capsule

Development stage: Unknown
Lead developer: Shandong University of Traditional Chinese Medicine
Administration: Oral

Overview

**Luole capsule** is an orally administered traditional Chinese medicine and natural-medicine investigational product developed by Shandong University of Traditional Chinese Medicine for adjunctive cancer treatment. It has been evaluated in multicenter, randomized, double-blind, placebo-controlled Phase 2 studies in primary liver cancer and primary non-small cell lung cancer in patients with the traditional Chinese medicine pattern of qi deficiency and blood stasis. Public trial records do not disclose its precise botanical composition, molecular targets, or direct pharmacologic mechanism; it should not be assumed to be a simple basil extract solely from the English rendering \"Basil Capsule.\" ([jkshiyao.com](https://www.jkshiyao.com/ExpertTeam/1551.html))

Other names: Basil CapsuleLuole罗勒胶囊

Beyond the preview

Go deeper on Luole capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Luole capsule.

Explore the full profile